Eve Holding heads into its August 4 earnings report with options traders sending an unusually sharp defensive signal — the most striking single data point in an otherwise mixed picture.
The options market has shifted dramatically in just two sessions. The put/call ratio jumped to 0.34 on July 21, almost three standard deviations above its 20-day average of 0.09. That average is itself near the bottom of the 52-week range, so the move is relative — but the z-score of 2.90 makes this the most defensive options posture Eve has seen in months. The shift is abrupt: from July 7 through July 16 the PCR barely moved above 0.08. Something changed on July 17-18 and accelerated into the week's close, with the PCR holding near 0.36. Whether this reflects genuine hedging ahead of results or opportunistic buyers picking up cheap downside insurance on a low-priced small-cap, the volume of put activity relative to recent norms is hard to ignore.
Short positioning, by contrast, tells a calmer story. Short interest runs at 2.8% of the free float — low by most standards, and barely changed over the past month (down 1.2% over 30 days). The borrow market is loose. Availability at 171%, against a 52-week trough of 30%, means lenders hold roughly 34 million shares available relative to current short positions. Cost to borrow has eased to 0.69% from just under 0.91% a week ago — a level that signals no urgency among short sellers to pay a premium to get in. The ORTEX short score has climbed from 64 in early July to 70 now, but that reflects a gradual drift, not a sudden surge in bearish conviction. Positioning here looks watchful rather than aggressive.
The Street remains constructive but has been quietly trimming ambition. Every analyst who has moved on EVEX in the past 12 months kept a Buy or Overweight rating while lowering their price target — Canaccord Genuity cut to $7.25 from $7.50 in May, JP Morgan trimmed to $6.00 from $7.00 in March, and Cantor Fitzgerald matched that move simultaneously. The consensus mean target sits at $6.39 against a current price of $2.45 — implying substantial upside on paper, but the repeated downward target revisions suggest the Street is anchoring to the long-term eVTOL opportunity while acknowledging that near-term milestones are slipping. EPS surprise ranks in the 80th percentile across the factor universe, a bright spot, though 30-day and 90-day EPS momentum factor scores sit in the bottom quintile at 12 and 15 respectively. Valuation multiples are negative across the board — PE, EV/EBITDA, price-to-book — which is expected for a pre-revenue developer but limits the toolkit for traditional buyers.
The ownership structure is worth noting because it defines the float dynamic. Embraer holds 71.9% of shares, leaving a thin freely traded slice. BlackRock added 195,000 shares to its position as of June 30, and State Street added 443,000 over the same period — modest institutional accumulation but not nothing. United Airlines Ventures maintains a stake of 0.76%, a reminder that strategic partners beyond Embraer have skin in the game. The insider data is stale (the most recent trade on record was Embraer's $20 million purchase in September 2025), so there is no recent management-level signal to read into.
Among the closest correlated peers, ACHR rose 8.9% on the week against EVEX's 2.5% gain. EVTL was flat over the same period. The eVTOL complex broadly moved higher — EVEX participated, but lagged its highest-correlation peer by more than six percentage points. The stock has also shed 13% over the past month, meaning the weekly rebound recovered only a fraction of recent losses.
The prior two earnings prints produced first-day moves of +7% and +14% respectively, with five-day follow-through of +22% and +14% — a pattern of sharp upside surprises. August 4 is therefore less about whether analysts expect progress and more about whether the Eve-100 test flight timeline and cash burn commentary land in line with a market that has already repriced expectations materially lower from the stock's highs.
See the live data behind this article on ORTEX.
Open EVEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.